Lineage

From device telemetry to patient signal systems.

Diabetech began with connected devices, evolved into disease-management and population-health programs, exited into virtual care infrastructure, then re-emerged in regulated clinical development and PatientStories.ai.

01CompaqiPAQ PDA + GPRS jacket: mobile data before smartphones.
02DiabetechJune 2001 inception; 2001 patent application; Dec. 19, 2002 field deployment with actual patients.
03HealthCordiaDisease-management programs and structured patient engagement, including Medicaid-scale virtual diabetes operations.
04HealthimoPopulation-health and international deployment framing.
05Philips Virtual Care ManagementCommercial virtual-care lineage.
06UltragenyxCrossing the chasm into GCP-grade clinical trial operations.
07Operational TelemetryDDC and STP live examples reflected in public BeyondXLH program materials: software-driven patient data workflows and aggregated, de-identified community statistics displayed on the web in near real time.
08COVID-19External stress test: remote workflows became necessary, not optional.
09FDA Real-Time Clinical TrialsRegulatory validation of live signal systems.
10PatientStories.aiReal-life narratives and signals become structured insight.

Data from daily life should become usable signal.

Usable signal should trigger workflow.

Workflow should reach the person who can act before the moment is lost.